bioAffinity Technologies BIAF
NASDAQ BIAF
$2.20 -0.14 (-5.98%)
At close: Nov 13, 2026 · 4:00 PM EST

bioAffinity Technologies (BIAF) Current Deferred Revenue (2023 - 2026)

Updated

bioAffinity Technologies (BIAF) posted Current Deferred Revenue of $48,874 for Q3 2026, up 28.9% from $37,915 a year earlier and up 56.9% from the prior quarter.

Analysis

bioAffinity Technologies (BIAF) Current Deferred Revenue (2023 - 2026) Analysis & Trends

At the end of FY2025, bioAffinity Technologies' Current Deferred Revenue came in at $42,405, up 73.8% from FY2024.

  • In prior years, bioAffinity Technologies' Current Deferred Revenue was $24,404 in FY2024 (-26.2%) and $33,058 in FY2023.
  • The Q3 2026 figure stands as the highest quarterly Current Deferred Revenue in data going back to Q2 2023.
  • On a year-over-year basis, Current Deferred Revenue has increased in each of the last five quarters, with growth averaging 20.2% over the last eight quarters.
  • The strongest year-over-year quarter for Current Deferred Revenue in the past five years was Q4 2025, with growth of 73.8%; the weakest was Q2 2024, with a decline of 38.9%.
  • According to Business Quant data, Current Deferred Revenue for the three prior quarters was $31,140 (Q2 2026), $31,140 (Q1 2026) and $42,405 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 105.29 Bn 103.13 Bn 17.03 Bn
2 Natera 46.06 Bn 41.68 Bn 513.47 Mn
3 Labcorp Holdings 30.09 Bn 28.19 Bn 1.11 Bn
4 Quest Diagnostics 28.58 Bn 26.66 Bn 1.04 Bn
5 Guardant Health 20.44 Bn 16.05 Bn 236.15 Mn
6 BrightSpring Health Services 14.16 Bn 11.04 Bn 518.55 Mn
7 Encompass Health 13.83 Bn 14.29 Bn 1.54 Bn
8 Tempus AI 12.69 Bn 9.84 Bn 266.70 Mn
9 Davita 11.06 Bn 9.92 Bn 1.13 Bn
10 bioAffinity Technologies 1.97 Mn -12.61 Mn -43,896.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 48,874.00
Jun 30, 2026 31,140.00
Mar 31, 2026 31,140.00
Dec 31, 2025 42,405.00
Sep 30, 2025 37,915.00
Jun 30, 2025 24,404.00
Mar 31, 2025 24,404.00
Dec 31, 2024 24,404.00
Sep 30, 2024 24,404.00
Jun 30, 2024 26,135.00
Mar 31, 2024 30,174.00
Dec 31, 2023 33,058.00
Sep 30, 2023 38,250.00
Jun 30, 2023 42,750.00
API Access

bioAffinity Technologies Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BIAF&period=max&api_key=YOUR_API_KEY